FindTrial
Sign In

Effect of Amrutha Bhallataka Lehya after Virechana over Madhusnuhi Rasayanam after Virechana in patients of Psoriasis

Efficacy of Amrutha Bhallataka Lehya after Virechana over Madhusnuhi Rasayanam after Virechana in the management of Kitibha Kushta (Psoriasis) - An Open Labelled Randomised Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072926
Enrollment
72
Registered
2024-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) AGE: 21-60 years, irrespective of sex, religion and occupation 2) Patients having signs and symptoms of Kitibha Kushta (Psoriasis) (ICD-11 Psoriasis EA 90) 3) Patients who are Snehapana yogya and Virechana yogya

Exclusion criteria

Exclusion criteria: 1) Lactating and pregnant women. 2) Patients suffering from uncontrolled diabetes and hypertension, Renal disease, Liver disease, CAD, IHD, Cancer, Immune deficiency disorder like AIDS. 3) Other forms of psoriasis like Pustular psoriasis (EA 90.4) and Erythrodermic psoriasis (EA 90.3). 4) Patients showing complications of Psoriasis, Psoriatic Arthropathy with deformity, addiction to alcohol. 5) Patients having H/o. any allergy to the ingredients of Interventional drugs.

Design outcomes

Primary

MeasureTime frame
1. To reduce the clinical signs and symptoms of Kitibha Kushta (Psoriasis) - shyava, kinakharasparsha, ruksha, parusha, kandu. 2. To bring out the difference in the Psoriasis Area Severity Index (PASI) score. Timepoint: Baseline After 8 weeks After 14 weeks—

Secondary

MeasureTime frame
To improve the– 1. Psoriasis Disability Index (PDI). 2. Dermatology Life Quality Index (DLQI) of Psoriatic patients. 3. Psoriasis Life Stress Inventory Scale (PLSI). Timepoint: Baseline After 14 weeks—

Countries

India

Contacts

Public ContactProfessor Dr Jonah S

All India Institute Of Ayurveda

jonahdr@gmail.com9448262298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026